adenosine monophosphate has been researched along with 3-(2,2,2-trimethylhydrazine)propionate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guseva, OG; Kalvin'sh, IIa; Logaĭ, IM | 1 |
| Abiko, Y; Akahira, M; Hara, A | 1 |
| Asaka, N; Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Tajima, K | 1 |
3 other study(ies) available for adenosine monophosphate and 3-(2,2,2-trimethylhydrazine)propionate
| Article | Year |
|---|---|
[The use of lysosomotropic preparations in treating severe experimental chemical eye burns].
Topics: Acute Disease; Adenosine Monophosphate; Animals; Burns, Chemical; Caustics; Cornea; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eye Burns; Lysosomes; Methylhydrazines; Rabbits; Time Factors | 1989 |
Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Administration, Oral; Animals; gamma-Butyrobetaine Dioxygenase; Heart; Hydrogen Peroxide; Male; Methylhydrazines; Mixed Function Oxygenases; Phosphocreatine; Rats; Rats, Sprague-Dawley; Ventricular Function | 1997 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiovascular Agents; gamma-Butyrobetaine Dioxygenase; Heart Failure; Heart Ventricles; Hemodynamics; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Survival Rate | 2000 |